Pharmaceutical Marketing News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

A NJ County Sues Purdue Pharma, Sackler Family for Opioid Marketing - Wall Street Journal



Wall Street Journal
 
A NJ County Sues Purdue Pharma, Sackler Family for Opioid Marketing 
Wall Street Journal
Camden County in southern New Jersey has joined hundreds of counties nationwide in suing the opioid-painkiller manufacturer Purdue Pharma L.P., but in an unusual step it also named as co-defendants members of the company's controlling family, the ...
Camden County sues drug makers to recoup the millions its spent fighting opioid crisis WHYY
In a legal first, Camden County files racketeering suit against OxyContin makers ROI-NJ.com
New Jersey county sues OxyContin maker, alleges racketeering Kansas City Star
Cherry Hill Courier Post 
all 27 news articles » 


Pharmaceutical Market Research Key Players, Industry Overview, Supply Chain and Analysis to 2018 ? 2022 - Facts of Week



Pharmaceutical Market Research Key Players, Industry Overview, Supply Chain and Analysis to 2018 ? 2022 
Facts of Week
North America Pharma and Healthcare Social Media market Forecasts -2022 Report approximately the manufacturing process. The process is analysed thoroughly with respect three points, viz. raw material and equipment suppliers, various manufacturing ...

and more » 


Purdue Pharma, maker of OxyContin, backs off aggressive marketing amid lawsuits - CBS News



CBS News
 
Purdue Pharma, maker of OxyContin, backs off aggressive marketing amid lawsuits 
CBS News
NEW YORK -- Monday marked a change of culture for Purdue Pharma, the drug company that makes OxyContin and other opioids. The company will no longer market those drugs to doctors and is laying off half its sales force. After years of marketing ...
The maker of OxyContin will finally stop marketing the addictive opioid to doctors Vox
Drugmakers Spent Millions Promoting Opioids To Patient Groups, Senate Report Says NPR
Purdue Pharma will no longer promote opioids to doctors Axios
CNN  -Bloomberg 
all 126 news articles » 


Plastic Pallet Market Segmentation and Analysis by Recent Trends, Development and Growth by Regions to 2022 - Facts of Week



Plastic Pallet Market Segmentation and Analysis by Recent Trends, Development and Growth by Regions to 2022 
Facts of Week
North America Pharmaceutical market Forecasts -2022 Report approximately the manufacturing process. The process is analysed thoroughly with respect three points, viz. raw material and equipment suppliers, various manufacturing associated costs ...

and more » 


OxyContin maker Purdue Pharma to stop marketing opioids to doctors - Marketplace.org



Marketplace.org
 
OxyContin maker Purdue Pharma to stop marketing opioids to doctors 
Marketplace.org
Purdue Pharma, the company behind prescription painkiller OxyContin said it will stop marketing opioid drugs to doctors, bowing to a key demand of lawsuits that blame the company for helping trigger the current drug abuse epidemic. The company ...
Purdue Pharmaceuticals Says It Will Stop the Aggressive Opioid Marketing That Made It Billions Gizmodo
Capping years of criticism, Purdue Pharma will stop promoting its opioid drugs to doctors Los Angeles Times
Purdue Pharma says it will stop promoting opioids to doctors CNNMoney
Q13 FOX  -The Globe and Mail  -The Hill  -Bloomberg 
all 127 news articles » 


Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission's ... - GlobeNewswire (press release)



Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission's ... 
GlobeNewswire (press release)
... to MainPointe Pharmaceuticals, LLC (?MainPointe?). In addition, the marketing rights of additional consumer products have been licensed by Mission to MainPointe. As part of these transactions, the companies have also entered into a renewable ...

and more » 


Doctors In Maine Say Halt In OxyContin Marketing Comes '20 Years Late' - NPR



NPR
 
Doctors In Maine Say Halt In OxyContin Marketing Comes '20 Years Late' 
NPR
The maker of OxyContin, one of the most prescribed and aggressively marketed opioid painkillers, will no longer tout the drug or any other opioids to doctors. The announcement, made Saturday, came as drugmaker Purdue Pharma faces lawsuits for deceptive ...
Purdue Pharma Discontinues Doctor Marketing Addiction Now
Drug Overdose Death Data | Drug Overdose | CDC Injury Center CDC
The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy - NCBI - NIH NCBI - NIH
National Conference of State Legislatures  -Purdue Pharma  -Maine Medical Association 
all 64 news articles » 


Additional PNW Governments Vote To Sue Opioid Manufacturers - KUOW News and Information



Additional PNW Governments Vote To Sue Opioid Manufacturers 
KUOW News and Information
?This will not be handled at the state Legislature, it won't happen in Congress,? Boldt said. ?The only place this will get handled is the local government.? Drug companies deny the claims and have said litigation should stop until Food and Drug ...

and more » 


FDA OKs Osmotica Pharma's PD med Osmolex; rival Adamas Pharma down 12% premarket - Seeking Alpha



FDA OKs Osmotica Pharma's PD med Osmolex; rival Adamas Pharma down 12% premarket 
Seeking Alpha
Adamas Pharmaceuticals (NASDAQ:ADMS) slumps 12% premarket on average volume on the heels of FDA approval of privately held Osmotica Pharmaceutical's OSMOLEX ER (amantadine) for the treatment of Parkinson's disease (PD) and drug-induced extrapyramidal ...

and more » 


Global Vasculitis Drug Market 2018 ? Bayer, Farmalider, Hainan Pharmaceutical Factory - Public Reporter



Public Reporter
 
Global Vasculitis Drug Market 2018 ? Bayer, Farmalider, Hainan Pharmaceutical Factory 
Public Reporter
Global Vasculitis Drug Market Report provides historical data for Vasculitis Drug market along with forecast and expected growth rate during the forecast period 2017-2025. Vasculitis Drug Market report studies the global Vasculitis Drug industry based ...

and more »